Literature DB >> 15853508

Nonpharmacological and pharmacological interventions for symptoms in Alzheimer's disease.

Ross Overshott1, Jane Byrne, Alistair Burns.   

Abstract

Patients with Alzheimer's disease may suffer from noncognitive symptoms as well as cognitive symptoms, which the condition is better known for. Behavioral and psychiatric symptoms are common in patients with Alzheimer's disease and may cause great distress to them and their carers. Symptoms include agitation, aggression, wandering, shouting, depression, apathy and sleep disturbance. The safe and effective management of behavioral and psychiatric symptoms of Alzheimer's disease is one of the greatest challenges clinicians face. Traditionally, pharmacological interventions have been the mainstay of treatment but there is growing evidence for the effectiveness of a wide range of nonpharmacological measures. In this review, the evidence and appropriateness of both types of intervention for behavioral and psychiatric symptoms in Alzheimer's disease are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15853508     DOI: 10.1586/14737175.4.5.809

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  4 in total

Review 1.  Treatment of dementia.

Authors:  R Overshott; A Burns
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

Review 2.  Epidemiology and management of apathy in patients with Alzheimer's disease.

Authors:  Romina Mizrahi; Sergio E Starkstein
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 3.  Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.

Authors:  Ruth Benca; W Joseph Herring; Rezaul Khandker; Zaina P Qureshi
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 4.  Pharmacological interventions for apathy in Alzheimer's disease.

Authors:  Myuri T Ruthirakuhan; Nathan Herrmann; Eleenor H Abraham; Sarah Chan; Krista L Lanctôt
Journal:  Cochrane Database Syst Rev       Date:  2018-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.